Insider Transactions in Q1 2019 at Eli Lilly & CO (LLY)
Insider Transaction List (Q1 2019)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 01
2019
|
David A Ricks President, Chair, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,222
+8.49%
|
-
|
Feb 01
2019
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
4,364
-8.57%
|
$519,316
$119.86 P/Share
|
Feb 01
2019
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
BUY
Exercise of conversion of derivative security
|
Direct |
9,722
+16.02%
|
-
|
Jan 31
2019
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
4,000
-8.84%
|
$480,000
$120.0 P/Share
|
Jan 22
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
93
+0.21%
|
$10,881
$117.09 P/Share
|
Jan 22
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+1.1%
|
$10,647
$117.09 P/Share
|
Jan 22
2019
|
Ellen R Marram Director |
BUY
Grant, award, or other acquisition
|
Direct |
58
+0.1%
|
$6,786
$117.09 P/Share
|
Jan 22
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.03%
|
$1,989
$117.09 P/Share
|
Jan 22
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+28.72%
|
$9,945
$117.09 P/Share
|
Jan 17
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
136,577
-0.06%
|
$16,116,086
$118.47 P/Share
|
Jan 16
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
1,657
-0.0%
|
$193,869
$117.87 P/Share
|
Jan 15
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
51,766
-0.04%
|
$6,056,622
$117.74 P/Share
|